These last two years have presented challenges for all organizations, but I want to express my utmost admiration to Cyndi Burkhardt and the entire team at Hoosier Cancer Research Network as we endured another year of challenges. The growth I have seen of Hoosier Cancer Research Network throughout my almost decade as chairman has been a product of Cyndi’s leadership. We would not have our highly qualified team, our reach as a network, and our strong collaborations if not for her leadership and guidance.

Hoosier Cancer Research Network remains equipped to support impactful clinical trials that answer crucial questions for cancer patients in communities nationwide.

As we continue to make meaningful gains in cancer research, it is a privilege to witness the important work of the HCRN staff in all areas of responsibility. Through their efforts, we are making real, measurable progress against cancer. It takes a team with vision to make such an impact.

As the pursuit of our goal to beat cancer continues, the key to our success is collaboration. Each year, the number and strength of investigators, institutions, community sites, pharmaceutical and biotech companies with whom we collaborate increases.

The strength of our collaborations and the leadership exhibited by our working groups and administrative team have powered our sails through these uncertain times. With these strengths, Hoosier Cancer Research Network is positioned for many strong years ahead.

Read more in the 2021 Annual Report 

– Christopher A. Fausel, PharmD, MHA, BCOP, chairman of the Board of Directors, Hoosier Cancer Research Network; clinical manager, Oncology Pharmacy, Indiana University School of Medicine
Read more in HCRN’s 2021 Annual Report.

About Hoosier Cancer Research Network

Hoosier Cancer Research Network (formerly known as Hoosier Oncology Group) conducts innovative cancer research in collaboration with academic and community physicians and scientists across the United States. The organization provides comprehensive clinical trial management and support, from conception through publication. Created in 1984 as a program of the Walther Cancer Institute, Hoosier Cancer Research Network became an independent nonprofit clinical research organization in 2007. Since its founding, Hoosier Cancer Research Network has conducted more than 230 trials in a variety of cancer types and supportive care, resulting in more than 350 publications. More than 9,000 subjects have participated in Hoosier Cancer Research Network clinical trials.